Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Propranolol 160mg modified-release capsules |
BNF code | 0204000R0AAABAB |
Virtual Therapeutic Moiety | Propranolol |
Date identifier became valid | 15 Jul 2020 |
Previous product identifier | 318406005 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | capsule |
Unit dose unit of measure | capsule |
Virtual Product Ingredient | |
---|---|
Ingredient | Propranolol hydrochloride |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 160.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | capsulemodified-release.oral |
Dose Form | |
Formulation | Modified-release capsule |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Bedranol SR 160mg capsules (Almus Pharmaceuticals Ltd) | |
Bedranol SR 160mg capsules (Sandoz Ltd) | |
Beta-Prograne 160mg modified-release capsules (Accord-UK Ltd) | |
Beta-Prograne 160mg modified-release capsules (Tillomed Laboratories Ltd) | |
Virtual Medicinal Product Packs | |
Propranolol 160mg modified-release capsules 100 capsule | |
Propranolol 160mg modified-release capsules 28 capsule | |
Propranolol 160mg modified-release capsules 56 capsule |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.